Byung-Heon Lee

6.0k total citations · 2 hit papers
128 papers, 4.8k citations indexed

About

Byung-Heon Lee is a scholar working on Molecular Biology, Immunology and Immunology and Allergy. According to data from OpenAlex, Byung-Heon Lee has authored 128 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Molecular Biology, 37 papers in Immunology and 27 papers in Immunology and Allergy. Recurrent topics in Byung-Heon Lee's work include Cell Adhesion Molecules Research (21 papers), RNA Interference and Gene Delivery (20 papers) and Immunotherapy and Immune Responses (15 papers). Byung-Heon Lee is often cited by papers focused on Cell Adhesion Molecules Research (21 papers), RNA Interference and Gene Delivery (20 papers) and Immunotherapy and Immune Responses (15 papers). Byung-Heon Lee collaborates with scholars based in South Korea, United States and India. Byung-Heon Lee's co-authors include In‐San Kim, Rang‐Woon Park, Sri Murugan Poongkavithai Vadevoo, Gowri Rangaswamy Gunassekaran, In-San Kim, Moon‐Chang Baek, Jung‐Eun Kim, Rang‐Woon Park, Je‐Yong Choi and Ick Chan Kwon and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Byung-Heon Lee

125 papers receiving 4.8k citations

Hit Papers

M1 macrophage exosomes engineered to foster M1 polarizati... 2021 2026 2022 2024 2021 2023 100 200 300

Peers

Byung-Heon Lee
Simon T. Barry United Kingdom
Abdel Kareem Azab United States
Jay S. Desgrosellier United States
Young Mo Kang South Korea
Rang‐Woon Park South Korea
Byung-Heon Lee
Citations per year, relative to Byung-Heon Lee Byung-Heon Lee (= 1×) peers Mirco Ponzoni

Countries citing papers authored by Byung-Heon Lee

Since Specialization
Citations

This map shows the geographic impact of Byung-Heon Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Byung-Heon Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Byung-Heon Lee more than expected).

Fields of papers citing papers by Byung-Heon Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Byung-Heon Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Byung-Heon Lee. The network helps show where Byung-Heon Lee may publish in the future.

Co-authorship network of co-authors of Byung-Heon Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Byung-Heon Lee. A scholar is included among the top collaborators of Byung-Heon Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Byung-Heon Lee. Byung-Heon Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Je Hyeong, Ju‐Hyun Bae, Il Hyo Jung, et al.. (2025). Plant-derived nanovesicles and therapeutic application. Pharmacology & Therapeutics. 269. 108832–108832. 10 indexed citations
2.
Lee, Young‐Jin, et al.. (2025). Strategic Optimization of Nanoparticle Characteristics to Enhance Tumor Targeting and Doxorubicin Delivery. International Journal of Nanomedicine. Volume 20. 6357–6378.
3.
Choi, Young‐Ae, Soyoung Lee, Byung-Heon Lee, et al.. (2023). IRF3 Activation in Mast Cells Promotes FcεRI-Mediated Allergic Inflammation. Cells. 12(11). 1493–1493. 3 indexed citations
4.
Kim, Minseong, Hee Jung Yoon, Chanju Lee, et al.. (2023). Immune Checkpoint-Blocking Nanocages Cross the Blood–Brain Barrier and Impede Brain Tumor Growth. ACS Biomaterials Science & Engineering. 10(1). 575–587. 9 indexed citations
5.
Vadevoo, Sri Murugan Poongkavithai, Gowri Rangaswamy Gunassekaran, Sehyun Chae, et al.. (2021). The macrophage odorant receptor Olfr78 mediates the lactate-induced M2 phenotype of tumor-associated macrophages. Proceedings of the National Academy of Sciences. 118(37). 89 indexed citations
6.
Kim, Yun-Jae, et al.. (2021). Therapeutic Effect of IL-4 Receptor-Targeting Pro-Apoptotic Peptide (AP1-ELP-KLAK) in Glioblastoma Tumor Model. International Journal of Nanomedicine. Volume 16. 5039–5052. 9 indexed citations
7.
Kwon, Tae-Jun, Rang‐Woon Park, Byung-Heon Lee, et al.. (2021). Development of a Noninvasive KIM-1-Based Live-Imaging Technique in the Context of a Drug-Induced Kidney-Injury Mouse Model. ACS Applied Bio Materials. 4(2). 1508–1514. 4 indexed citations
8.
Lee, Young‐Jin, et al.. (2020). Targeting of Cisplatin-Resistant Melanoma Using a Multivalent Ligand Presenting an Elastin-like Polypeptide. ACS Biomaterials Science & Engineering. 6(9). 5024–5031. 9 indexed citations
9.
Vadevoo, Sri Murugan Poongkavithai, Jung‐Eun Kim, Gowri Rangaswamy Gunassekaran, et al.. (2017). IL4 Receptor–Targeted Proapoptotic Peptide Blocks Tumor Growth and Metastasis by Enhancing Antitumor Immunity. Molecular Cancer Therapeutics. 16(12). 2803–2816. 34 indexed citations
10.
Kwon, Hee Jung, et al.. (2017). Elevated Interleukin-13 Receptor Alpha 1 Expression in Tumor Cells Is Associated with Poor Prognosis in Patients with Invasive Breast Cancer. Annals of Surgical Oncology. 24(12). 3780–3787. 21 indexed citations
11.
Lee, Byung-Heon, et al.. (2014). The Effect of Government R&D Supports on SME's Technological Innovation Performance in Korea. Asia-Pacific Journal of Business Venturing and Entrepreneurship. 9(5). 157–171. 3 indexed citations
12.
Nam, Ju-Ock, Hye‐Nam Son, Eunsung Jun, et al.. (2012). FAS1 Domain Protein Inhibits VEGF165-Induced Angiogenesis by Targeting the Interaction between VEGFR-2 and αvβ3 Integrin. Molecular Cancer Research. 10(8). 1010–1020. 11 indexed citations
13.
Lee, Min Jeong, Kai Wang, In-San Kim, Byung-Heon Lee, & Hyung Soo Han. (2011). Molecular Imaging of Cell Death in an Experimental Model of Parkinson’s Disease with a Novel Apoptosis-Targeting Peptide. Molecular Imaging and Biology. 14(2). 147–155. 10 indexed citations
14.
Lee, Byung-Heon, et al.. (2008). Comparison of Technological Innovation and Performance between Innovative SMEs and General SMEs: Empirical Evidence and Policy Implications. 11(1). 79–100. 1 indexed citations
15.
Lee, Byung-Heon, et al.. (2008). The Impact of Exploration, Exploitation, and R&D Organization on Innovations in the Korean SMEs. Journal of Korea Technology Innovation Society. 11(1). 118–143. 3 indexed citations
16.
Lee, Seung-Min, Eun‐Ju Lee, Tae‐Hwan Kwon, et al.. (2007). Targeting Bladder Tumor Cells In vivo and in the Urine with a Peptide Identified by Phage Display. Molecular Cancer Research. 5(1). 11–19. 84 indexed citations
17.
Lee, Byung-Heon. (2005). Technological innovation strategies of Korean ventures across the growth stages and the effect of government R&D subsidy. 8(2). 127–152. 3 indexed citations
18.
Lee, Byung-Heon, et al.. (1995). Effect of Cyclic AMP on the Collagen Production and Degradation in Human Lung Fibroblasts. Experimental & Molecular Medicine. 27(1). 9–14. 1 indexed citations
19.
Park, Rang‐Woon, et al.. (1995). Collagen Synthesis in Fibroblasts from Keloid Lesions and Their Responses to Transforming Growth Factor-β. Experimental & Molecular Medicine. 27(4). 209–217. 1 indexed citations
20.
Lee, Byung-Heon. (1992). Changes in The Industry Environment and Strategic Changes of Businesses : The Korean Tile Industry 1986~1990. Journal of the Korean Operations Research and Management Science Society. 17(3). 101–135. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026